Josep Rodés-Cabau

Showing 1-20 of 24 articles

Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis

Schlotter F, Miura M, Kresoja K, Alushi B, Alessandrini H, Attinger-Toller A, Besler C, Biasco L, Braun D, Brochet E, Connelly K, de Bruijn S, Denti P, Estevez-Loureiro R, Fam N, Gavazzoni M, Himbert D, Ho E, Juliard J, Kalbacher D, Kaple R, Kreidel F, Latib A, Lubos E, Ludwig S, Mehr M, Monivas V, Nazif T, Nickenig G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Rommel K, Schäfer U, Schofer J, Sievert H, Tang G, Thiele H, Unterhuber M, Vahanian A, von Bardeleben R, von Roeder M, Webb J, Weber M, Wild M, Windecker S, Zuber M, Hausleiter J, Maisano F, Leon M, Hahn R, Lauten A, Taramasso M, Lurz P

July 20, 2021 | 10.4244/EIJ-D-21-00191

Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction

Rodés-Cabau J, Ribeiro H

October 23, 2020 | 10.4244/EIJV16I8A114

Coronary interventions

Angiography-based quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis

Mejía-Rentería H, Nombela-Franco L, Paradis J, Lunardi M, Lee J, Amat-Santos I, Veiga Fernandez G, Kalra A, Bansal E, de la Torre Hernandez J, Rodés-Cabau J, Ribichini F, Escaned J

July 17, 2020 | 10.4244/EIJ-D-19-01001

Interventions for heart failure

Interatrial shunt with the second-generation V-Wave system for patients with advanced chronic heart failure

Guimarães L, Bergeron S, Bernier M, Rodriguez-Gabella T, del Val D, Pibarot P, Eigler N, Abraham W, Rodés-Cabau J

March 20, 2020 | 10.4244/EIJ-D-19-00291

The Atrial Flow Regulator device: expanding the field of interatrial shunting for treating heart failure patients

Guimarães L, del Val D, Rodés-Cabau J

August 29, 2019 | 10.4244/EIJV15I5A73

Interventions for heart failure

Interatrial shunting for heart failure: current evidence and future perspectives

Guimarães L, Lindenfeld J, Sandoval J, Bayés-Genis A, Bernier M, Provencher S, Rodés-Cabau J

June 20, 2019 | 10.4244/EIJ-D-18-01211

Interventions for valvular disease

FORMA Tricuspid Repair System: device enhancements and initial experience

Asmarats L, Philippon F, Bedard E, Rodés-Cabau J

March 20, 2019 | 10.4244/EIJ-D-18-00956

Interventions for valvular disease

First-in-man use of the new-generation TriGUARD 3 cerebral embolic protection device during transcatheter aortic valve implantation

Paradis J, Nazif T, Rodés-Cabau J

December 7, 2018 | 10.4244/EIJ-D-18-00442

Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study

Maisano F, Worthley S, Rodés-Cabau J, Linke A, Fichtlscherer S, Schäfer U, Makkar R, Fontana G, Asch F, Søndergaard L

October 19, 2018 | 10.4244/EIJ-D-18-00343

Interventions for valvular disease

To nurture a snake in one’s bosom: aspiration of a giant right atrium thrombus after a MitraClip procedure

Paradis J, O’Connor K, Asmarats L, Rodés-Cabau J

October 12, 2018 | 10.4244/EIJ-D-18-00411

Interventions for valvular disease

Effect of size and position of self-expanding transcatheter valve on haemodynamics following valve-in-valve procedure in small surgical bioprostheses: an in vitro study

Zenses A-S, Evin M, Stanová V, Clavel M-A, Barragan P, Rodés-Cabau J, Obadia J, Pibarot P, Rieu R

June 14, 2018 | 10.4244/EIJ-D-17-00875

Interventions for valvular disease

Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial

Urena M, Del Trigo M, Altisent O, Campelo-Parada F, Regueiro A, Delarochelliere R, Doyle D, Mohammadi S, Paradis J, Dagenais F, Dumont E, Puri R, Laroche V, Rodés-Cabau J

May 15, 2017 | 10.4244/EIJ-D-16-00591

Interventions for valvular disease

Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience

Perlman G, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman M, LeBlanc H, Buller C, Rodés-Cabau J, Webb J

January 20, 2017 | 10.4244/EIJ-D-16-00299

Interventions for valvular disease

Transcatheter interventions for tricuspid regurgitation: the FORMA Repair System

Puri R, Rodés-Cabau J

September 18, 2016 | 10.4244/EIJV12SYA31

Interventions for valvular disease

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial

Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence M, Redwood S, Kahlert P, Rodés-Cabau J, Leipsic J, Webb J

June 10, 2016 | 10.4244/EIJV12I2A37

Interventions for valvular disease

Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications

Urena M, Rodés-Cabau J

September 17, 2015 | 10.4244/EIJV11SWA30

Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance

Ribeiro H, Larose E, de la Paz Ricapito M, Le Ven F, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Dahou A, Capoulade R, Clavel M-A, Mohammadi S, Paradis J, De Larochelliere R, Doyle D, Dumont E, Pibarot P, Rodés-Cabau J

June 19, 2015 | 10.4244/EIJV11I2A39

Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device

Amat-Santos I, Bergeron S, Bernier M, Allende R, Ribeiro H, Urena M, Pibarot P, Verheye S, Keren G, Yaacoby M, Nitzan Y, Abraham W, Rodés-Cabau J

January 22, 2015 | 10.4244/EIJY14M05_07

Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve

Nombela-Franco L, Ribeiro H, Urena M, Pasian S, Allende R, Doyle D, Delarochelliere R, DeLarochelliere H, Laflamme L, Laflamme J, Jerez-Valero M, Cote M, Pibarot P, Larose E, Dumont E, Rodés-Cabau J

April 22, 2014 | 10.4244/EIJV9I12A237

Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation

Houthuizen P, van der Boon R, Urena M, Van Mieghem N, Brueren G, Poels T, Van Garsse L, Rodés-Cabau J, Prinzen F, de Jaegere P

February 20, 2014 | 10.4244/EIJV9I10A194

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.